Moscow, Russia

Vadim Albertovich Makarov

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Moskau, RU (2017)
  • Moscow, RU (2013 - 2019)

Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Vadim Albertovich Makarov: Innovator in Pharmaceutical Chemistry

Introduction

Vadim Albertovich Makarov is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds useful in treating bacterial infections.

Latest Patents

Makarov holds five patents, with his latest innovations focusing on 2-homopiperazine-1-yl-4H-1,3-benzothiazine-4-one derivatives. These compounds are particularly valuable in the treatment of serious bacterial infections, including tuberculosis, buruli ulcer, and leprosy. Additionally, he has developed a process for the preparation of 2-(homo)piperazine 1,3-benzothiazine-4-one hydrochlorides, further enhancing the therapeutic potential of these derivatives.

Career Highlights

Throughout his career, Makarov has worked with prestigious institutions, including the École Polytechnique Fédérale de Lausanne and Scandion Oncology A/S. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Makarov has collaborated with notable colleagues such as Cole Stewart and Peter Wutzler. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Vadim Albertovich Makarov is a distinguished inventor whose work in pharmaceutical chemistry has the potential to significantly improve treatments for bacterial infections. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…